Healthcare New Frontier A Challenge from Kanagawa, Japan Message from the Governor In order to create a brighter future vision for the era of the su- per-aged society, Kanagawa, the second most populous prefecture in Japan adjacent to Tokyo, has been promoting a grand policy package called “Healthcare New Frontier (HCNF).” HCNF is a bundle of healthcare and industrial/regional policies. Its key concept is “Managing ME-BYO,” the scope of which is something broader than that of “disease prevention” in the context of Western medicine. Combining this concept with the utilization of advanced medical treatments and technologies, we aim to achieve healthy longevity of the citizens and to create new markets and industries at the same time. I would greatly appreciate your understanding and support in fulfilling our goals. HCNF will provide a solid base for everybody to lead a better life in the coming years. Yuji Kuroiwa Governor, Kanagawa Prefecture Healthcare Kanagawa Prefecture has developed “Healthcare New Frontier Promotion New Frontier Plan” to illustrate specific programs of Healthcare New Frontier Policy, and how the Prefecture will work with citizens to carry out such programs. Promotion For the realization of the ideal future society which the Prefecture envi- Plan sions, the Plan has set the following goals to be attained by the year 2025. Main Goal 1 Develop ME-BYO Index and Obtain 800,000 Users of ME-BYO Index Main Goal 2 Targets in Focused Areas •Diabetes patients down to the 220,000 level, 5% decrease from 2014 •Pre-metabolic and metabolic syndrome people down more than 25% from 2008 Main Goal 3 Create New Industries •The size of the ME-BYO and regenerative markets in Kanagawa to reach 250 billion yen Contact Information http://www.pref.kanagawa.jp/div/0121/ Healthcare New Frontier Promotion Phone +81-45-210-2725 Headquarters Office Fax +81-45-210-8865 Policy Bureau E-mail [email protected] Kanagawa Prefectural Government 1 Nihon-odori, Naka-ku, Yokohama, Kanagawa, 231-8588, Japan Three Special Zones Initiative for National Strategic Special Zone Kanagawa Prefecture has three special zones: the National Strategic Special Zone covering Tokyo(Haneda) the entire prefecture, the International Airport Sagami Robotics Industry Spe- cial Zone located along the Kawasaki sta. Sagami Jukan Expressway, and the Keihin Coastal Area Life Yokohama sta. Innovation Comprehensive Spe- Special Zone cial Zone centered around Yoko- for Robotics Industry hama and Kawasaki. (the Sagami Area) By utilizing the three special Special Zone zones and combining the two ap- for Life Science Industry proaches —utilizing advanced (the Greater Yokohama - Kawasaki Area) medical treatments and technol- ogies, and managing ME-BYO— Kanagawa is promoting the National Strategic HCNF Policy to create new busi- Special Zone nesses and innovations. Advantage 1. Location and Population Tokyo 14 million Kawasaki city Adjacent to Tokyo Yokohama city 1.5 million ・ Japan’s population: 126.3million 3.8 million Kanagawa pref. ・ No.2 among 47 prefectures with 9.2 million residents million ・ Comparable to the population of Austria (8.85million) 9.2 and Israel (8.88 million) USA 18.6 trillion China 11.2 trillion 2. Size of Economy GDP: Japan 4.9 trillion ($1=¥108.37) Prefectural GDP of approx.$319.4 billion Hong Kong 320.9 billion $319.4 Kanagawa 319.4 billion ・ Comparable to Hong Kong ($320.9billion) and Israel ($317.7billion) 317.7 billion (Source: FY2016 Kanagawa Prefecture Report on Prefectural Accounts) billion Israel 3. Transportation Tokyo Haneda Airport 30 min about Travel time from Haneda Airport to Yokohama by Rail 23km （HND） ・ from Yokohama (14.3mi) To Yokohama Station: approximately 30 minutes to Haneda Airport ・ To Kawasaki Station: approximately 15 minutes Yokohama 4. Corporations 302 Number of Foreign-affiliated Firms: 302 (No.2 after Tokyo) Foreign-affiliated (Source: Toyo Keizai Inc.“Directory of Foreign-owned Companies in Japan 2019” ) Firms 5. Human Resources and R&D 1st rank in Japan Number of Researchers: 63,000 people (No.1 in Japan) for number of ・ Kanagawa has the second most R&D labs and offices in Japan researchers Healthcare New Frontier Policy Healthcare New Frontier (HCNF) is a package of policies developed by the Kanagawa Prefectural Govern- ment to assist everybody to live a long and healthy life in the face of the severe social changes resulting from the advent of the super-aged society. Super-Aged Society Causing a Rapid Change in Population Structure The advancement of an ageing society is a common concern among industrial- Age 85 ~ 80 ~ 84 ized nations, with Japan experiencing the 1970 75 ~ 79 70 ~ 74 65 ~ 69 60 ~ 64 most rapid progress of an ageing society. 55 ~ 59 50 ~ 54 45 ~ 49 Kanagawa is one of the fastest ageing 40 ~ 44 35 ~ 39 Men30 ~ 34 Women 25 ~ 29 societies in Japan. 20 ~ 24 15 ~ 19 10 ~ 14 5 ~ 9 0 ~ 4 50403020100 0 10 20 30 40 50 Problems Arising from Changes (10K. people) Age in Population Structure 85 ~ 80 ~ 84 75 ~ 79 The current social welfare system with 2050 70 ~ 74 65 ~ 69 60 ~ 64 55 ~ 59 the working generation supporting elderly 50 ~ 54 45 ~ 49 Men 40 ~ 44 Women 35 ~ 39 citizens will not be sustainable with the 30 ~ 34 25 ~ 29 20 ~ 24 15 ~ 19 unprecedented changes in social struc- 10 ~ 14 5 ~ 9 0 ~ 4 ture demonstrated by the change in the 50403020100 0 10 20 30 40 50 population pyramid. Population Pyramid of Kanagawa (10K. people) Based on the national population census Dual Approaches to Solve the Issue of Population Ageing Kanagawa Prefecture has been promoting the HCNF Policy in order to address the issue of population ageing. The HCNF Policy consists of two approaches: pursuing cutting-edge medical treatments and tech- nologies, and managing ME-BYO. Advanced Medical Technologies Managing ME-BYO iPS cell research Life supporting robot Personal health record Daily food Exercise habit HAL® Prof. Sankai, through smartphone as medicine University of Tsukuba/CYBERDYNE Inc. Personalized Medicine Healthier Lifestyles Healthy Longevity and New Markets / Industries Mar. 2020 Biomedical Cluster Life Innovation Center in Kanagawa The Center for Regenerative Medicine and Cell Therapy Kanagawa Life Innovation Center (LIC) was launched in April 2016 for the industrialization of regenerative medicine Yokohama Station and cell therapy, a high-potential technology in the next gen- eration of medical care. Kawasaki Station The Center is located in Tonomachi Area, Kawasaki City, Tonomachi Area where cutting-edge companies and institutes in the life sci- ence field cluster. Utilizing this locational advantage, the Center accelerates the process from R&D to commercializa- tion of regenerative products to achieve application and industrialization of promising technology seeds in regenera- Promoting cooperation tive medicine and cell The bridge is scheduled to open among various technical seeds therapy. in FY 2020 4F Support for venture businesses International Tokyo International Airport Terminal (Haneda Airport) 3F Laboratory & Office Spaces One of the core projects of the Prefecture is taking place in Tonomachi Area, Kawasaki City, a National Strategic Spe- 2F Laboratory & Office Spaces cial Zone. This area along the Tama River is a Kanagawa’s Well-equipped Facilities and cutting-edge life science cluster, called “King Skyfront,” 1F Cell Culture, Production Convenient Research where various companies and institutes have moved in. In and Processing Environments FY2020 Tonomachi Area will be connected to Tokyo with a -Efficient R&D environment bridge, and enable quick access to Tokyo (Haneda) Interna- -Functional and versatile To all over the world interactive spaces and tional Airport only by fifteen minutes’ walk. from Tokyo (Haneda) International Airport meeting rooms Industry for School of Health Innovation Healthcare Robotics Healthcare robotics will play an essential role in address- In order to promote Healthcare New Frontier Policy, ing various issues of ageing. This technology is used not only Kanagawa Prefecture established a new master’s degree pro- in medical treatments, but also in support of frail seniors gram in Kanagawa University of Human Services, named and people with disabilities who need daily and long-term School of Health Innovation. care. Robotics also supports healthcare workers who aid such The School provides innovative education including public people. Japan is advanced in this field, and HCNF initiatives health, technology, business, administration and practical are utilizing this strength to build a new system of care and training in healthcare-related fields, and offers a Master of support. Public Health (MPH) degree. The classes are taught in both English and Japanese. Examples of Robotics Use in Kanagawa Center for the Promotion of Care Robot Scheme Purpose Development of human resources that can create innovations in healthcare-related fields Form of Installation Graduate School of Public Health founded in Kanagawa University of Human Services Address Tonomachi, Kawasaki City, Kanagawa Open April 2019 Course Term 2 years Therapeutic robot, Degree Obtained Master of Public Health PARO Cyborg-type Number of 15 per grade robot, HAL Humanoid robot, PARLO Students Advanced Approach Medical Technologies Europe ・Finland (Oulu) ・Germany(Baden-Württemberg) ・UK Japan has made a number of basic research achievements including Kanagawa, Japan the development of iPS Cells, but practical application of these research ・WHO results is rather slow compared with the West. Asia Kanagawa is promoting measures to turn the results of basic ・Singapore research into practical application such as development of revolution- ・India ary drugs, advanced medical equipment and regenerative medical prod- ・China Kanagawa Prefecture has been working hard to spread its important initiatives on the ucts, while stimulating the growth of the industries in these fields. healthcare fields through overseas collaborations.During the past several years, the dele The objectives for combining Kanagawa’s two approaches are to pro- gates from the Prefecture visited relevant government, academic and other organizations in long people’s healthy longevity, to expand areas for cutting-edge medi- many cities in Europe, Asia and the U.S.